John Hieu Duc Nguyen, MD
Otolaryngology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 4
Offices
4 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nguyen’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A91564 · Current
Licensed to practise in California · since 2005 · expires 2026-11-30 · University of California, Irvine College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$102,121
Medicare paid this office $102,121 for 321 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal or exploration of parathyroid glands | 21 | $18,102 | $862 |
| Short return visit (20+ min) | 126 | $13,371 | $77 |
| Return visit (30+ min) | 92 | $12,101 | $114 |
| Diagnostic exam of voice box using a flexible endoscope | 78 | $11,156 | $130 |
| New patient visit (30+ min) | 75 | $7,285 | $97 |
See all 11 services
| Removal or exploration of parathyroid glands | 21 | $18,102 | $862 |
| Short return visit (20+ min) | 126 | $13,371 | $77 |
| Return visit (30+ min) | 92 | $12,101 | $114 |
| Diagnostic exam of voice box using a flexible endoscope | 78 | $11,156 | $130 |
| New patient visit (30+ min) | 75 | $7,285 | $97 |
| Removal of impacted ear wax | 105 | $5,472 | $38 |
| New patient visit (45+ min) | 36 | $5,339 | $148 |
| Diagnostic exam of nasal passages using an endoscope | 22 | $5,141 | $190 |
| New patient visit (60+ min) | 13 | $2,570 | $198 |
| Simple control of nose bleed | 14 | $2,264 | $151 |
| Short return visit | 29 | $2,248 | $51 |
Who their Medicare patients are
321 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 18% · Women 59% · Also on Medicaid 14% · Health risk score 1.11. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 69% · Coronary heart disease 22% · Chronic kidney disease 22% · Atrial fibrillation 21% · Diabetes 20% · Depression 16% · Cancer 14% · Heart failure 11% · COPD 10% · Stroke 7% · Dementia 4%.
The office billed $423,995, Medicare allowed $135,537 and paid $102,121; for 830 services of 43 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 321 | 830 | 77 | 1.11 | $423,995 | $102,121 |
| 2023 | 297 | 780 | 76 | 0.87 | $426,656 | $104,984 |
| 2022 | 348 | 853 | 76 | 1.05 | $379,669 | $98,922 |
| 2021 | 368 | 927 | 76 | 1.01 | $412,585 | $110,441 |
| 2020 | 283 | 615 | 76 | 1.07 | $230,939 | $59,673 |
| 2019 | 315 | 728 | 75 | 1.08 | $322,554 | $76,635 |
| 2018 | 361 | 788 | 76 | 1.32 | $317,442 | $79,258 |
| 2017 | 343 | 807 | 76 | 1.10 | $305,067 | $76,589 |
| 2016 | 350 | 825 | 75 | 1.05 | $280,986 | $72,753 |
| 2015 | 354 | 842 | 76 | 1.07 | $259,786 | $76,102 |
| 2014 | 292 | 664 | 77 | 1.23 | $233,794 | $60,998 |
| 2013 | 321 | 700 | 76 | 1.23 | $222,375 | $57,871 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Removal or exploration of parathyroid glands | 23 | $19,642 | $854 |
| Diagnostic exam of voice box using a flexible endoscope | 83 | $11,454 | $133 |
| Return visit (30+ min) | 83 | $10,344 | $108 |
| Short return visit (20+ min) | 94 | $9,954 | $79 |
| New patient visit (30+ min) | 70 | $6,937 | $99 |
| New patient visit (45+ min) | 47 | $6,388 | $136 |
| Diagnostic exam of nasal passages using an endoscope | 19 | $5,846 | $195 |
| Removal of impacted ear wax | 93 | $5,496 | $41 |
| Short return visit | 31 | $2,611 | $48 |
| New patient visit (60+ min) | 11 | $2,330 | $212 |
2022: 12 services
| Removal or exploration of parathyroid glands | 19 | $15,972 | $841 |
| Diagnostic exam of voice box using a flexible endoscope | 87 | $12,087 | $131 |
| Short return visit (20+ min) | 107 | $11,629 | $81 |
| Return visit (30+ min) | 71 | $8,841 | $109 |
| New patient visit (30+ min) | 92 | $8,387 | $91 |
| Removal of impacted ear wax | 109 | $5,542 | $38 |
| New patient visit (45+ min) | 37 | $5,246 | $142 |
| Diagnostic exam of nasal passages using an endoscope | 17 | $5,161 | $199 |
| Long return visit (40+ min) | 26 | $4,891 | $169 |
| New patient visit (60+ min) | 19 | $3,296 | $173 |
| Short return visit | 46 | $3,155 | $51 |
| Exam of ear using a microscope | 12 | $329 | $21 |
2021: 14 services
| Removal or exploration of parathyroid glands | 17 | $15,908 | $884 |
| Short return visit (20+ min) | 120 | $12,279 | $79 |
| Diagnostic exam of voice box using a flexible endoscope | 83 | $11,726 | $135 |
| Return visit (30+ min) | 70 | $9,753 | $115 |
| New patient visit (30+ min) | 98 | $9,686 | $99 |
| New patient visit (45+ min) | 47 | $7,125 | $152 |
| Removal of impacted ear wax | 124 | $6,805 | $40 |
| Long return visit (40+ min) | 29 | $5,227 | $169 |
| Diagnostic exam of nasal passages using an endoscope | 17 | $4,382 | $209 |
| New patient visit (60+ min) | 21 | $4,184 | $199 |
| Simple control of nose bleed | 19 | $3,588 | $163 |
| Short return visit | 39 | $2,695 | $53 |
| New patient visit (15+ min) | 13 | $800 | $62 |
| Repositioning exercises of head for treatment of dizziness, each day | 12 | $599 | $43 |
2020: 7 services
| New patient visit (30+ min) | 114 | $10,445 | $92 |
| Short return visit (20+ min) | 101 | $8,804 | $65 |
| Diagnostic exam of voice box using a flexible endoscope | 59 | $8,081 | $124 |
| Removal of impacted ear wax | 101 | $4,791 | $39 |
| Return visit (30+ min) | 38 | $3,840 | $94 |
| Short return visit | 18 | $915 | $42 |
| New patient visit (15+ min) | 11 | $679 | $62 |
2019: 10 services
| Short return visit (20+ min) | 137 | $11,967 | $66 |
| New patient visit (30+ min) | 110 | $9,630 | $88 |
| Removal or exploration of parathyroid glands | 11 | $9,448 | $859 |
| Diagnostic exam of voice box using a flexible endoscope | 71 | $8,944 | $115 |
| Removal of impacted ear wax | 99 | $5,135 | $39 |
| Return visit (30+ min) | 51 | $4,893 | $91 |
| Diagnostic exam of nasal passages using an endoscope | 18 | $3,526 | $196 |
| New patient visit (45+ min) | 12 | $1,609 | $134 |
| Short return visit | 16 | $674 | $37 |
| Exam of ear using a microscope | 11 | $330 | $30 |
2018: 9 services
| New patient visit (30+ min) | 150 | $13,388 | $89 |
| Short return visit (20+ min) | 114 | $11,414 | $64 |
| Diagnostic exam of voice box using a flexible endoscope | 72 | $9,313 | $107 |
| Removal or exploration of parathyroid glands | 11 | $8,527 | $775 |
| Removal of impacted ear wax | 112 | $5,540 | $41 |
| Return visit (30+ min) | 54 | $5,363 | $89 |
| New patient visit (45+ min) | 16 | $2,191 | $137 |
| Short return visit | 19 | $895 | $41 |
| New patient visit (15+ min) | 11 | $789 | $72 |
2017: 10 services
| New patient visit (30+ min) | 165 | $14,001 | $85 |
| Short return visit (20+ min) | 101 | $9,011 | $61 |
| Diagnostic exam of voice box using a flexible endoscope | 71 | $8,872 | $111 |
| Return visit (30+ min) | 59 | $5,902 | $89 |
| Removal of impacted ear wax | 111 | $5,509 | $37 |
| Diagnostic exam of nasal passages using an endoscope | 13 | $2,946 | $210 |
| Simple control of nose bleed | 14 | $1,421 | $84 |
| Short return visit | 15 | $800 | $36 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 11 | $545 | $50 |
| Test to assess middle ear function | 11 | $149 | $14 |
2016: 10 services
| New patient visit (30+ min) | 153 | $14,183 | $93 |
| Short return visit (20+ min) | 119 | $9,892 | $60 |
| Diagnostic exam of voice box using a flexible endoscope | 63 | $7,145 | $110 |
| Removal of impacted ear wax | 117 | $6,262 | $40 |
| Return visit (30+ min) | 61 | $6,230 | $94 |
| Diagnostic exam of nasal passages using an endoscope | 19 | $3,766 | $198 |
| New patient visit (45+ min) | 15 | $2,202 | $147 |
| Short return visit | 30 | $1,710 | $36 |
| Simple control of nose bleed | 15 | $1,405 | $83 |
| Exam of ear using a microscope | 17 | $611 | $27 |
2015: 10 services
| New patient visit (30+ min) | 166 | $15,701 | $95 |
| Short return visit (20+ min) | 106 | $10,724 | $68 |
| Diagnostic exam of nasal passages using an endoscope | 19 | $6,840 | $201 |
| Removal of impacted ear wax | 132 | $6,644 | $43 |
| Diagnostic exam of voice box using a flexible endoscope | 56 | $6,630 | $114 |
| Return visit (30+ min) | 58 | $6,573 | $103 |
| Short return visit | 35 | $1,601 | $40 |
| Simple control of nose bleed | 16 | $1,476 | $78 |
| New patient visit (15+ min) | 22 | $1,140 | $52 |
| Exam of ear using a microscope | 23 | $1,046 | $31 |
2014: 12 services
| New patient visit (30+ min) | 134 | $12,140 | $91 |
| Short return visit (20+ min) | 87 | $6,581 | $59 |
| Diagnostic exam of voice box using a flexible endoscope | 46 | $5,686 | $109 |
| Removal of impacted ear wax | 94 | $4,465 | $41 |
| Return visit (30+ min) | 36 | $3,687 | $97 |
| Diagnostic exam of nasal passages using an endoscope | 12 | $2,462 | $189 |
| Exam of the nose and throat using an endoscope | 14 | $2,090 | $139 |
| Simple control of nose bleed | 17 | $1,769 | $84 |
| Short return visit | 38 | $1,685 | $36 |
| New patient visit (15+ min) | 16 | $1,049 | $66 |
| Exam of ear using a microscope | 15 | $505 | $25 |
| Repositioning exercises of head for treatment of dizziness, each day | 11 | $342 | $28 |
2013: 9 services
| New patient visit (30+ min) | 149 | $13,496 | $91 |
| Short return visit (20+ min) | 125 | $10,701 | $60 |
| Diagnostic exam of voice box using a flexible endoscope | 46 | $5,269 | $110 |
| Removal of impacted ear wax | 106 | $4,957 | $43 |
| Diagnostic exam of nasal passages using an endoscope | 17 | $3,749 | $221 |
| Return visit (30+ min) | 26 | $2,773 | $99 |
| Short return visit | 30 | $1,301 | $38 |
| Simple control of nose bleed | 15 | $1,190 | $74 |
| Exam of ear using a microscope | 23 | $1,127 | $31 |
Drugs they prescribed that Part D paid
$4,583
Pharmacies billed $4,583 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
181 generic and fewer than 11 brand-name prescriptions · $4,583 in drug cost · 31 antibiotic prescriptions to 24 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 43 | $1,112 | $26 |
| Fluocinolone Acetonide Oil | 20 | $699 | $35 |
| Ofloxacin | 12 | $425 | $35 |
| Amoxicillin-Clavulanate Potass | 13 | $124 | $10 |
Year by year
| 2024 | 188 | 90 | None | None | $4,583 |
| 2023 | 163 | 79 | None | None | $5,062 |
| 2022 | 162 | 80 | None | None | $6,071 |
| 2021 | 126 | 78 | None | None | $4,119 |
| 2020 | 137 | 65 | None | None | $4,817 |
| 2019 | 128 | 70 | None | 11% | $4,416 |
| 2018 | 131 | 70 | 10% (13) | None | $4,478 |
| 2017 | 187 | 81 | 7% (13) | None | $9,445 |
| 2016 | 224 | 94 | 8% (18) | 14% | $10,392 |
| 2015 | 219 | 87 | 5% (11) | None | $10,542 |
| 2014 | 216 | 95 | 6% (12) | 13% | $8,162 |
| 2013 | 190 | 90 | None | 12% | $7,164 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Ipratropium | 20 | $1,291 | $65 |
| Fluocinolone Acetonide Oil | 18 | $708 | $39 |
| Amoxicillin-Clavulanate Potass | 18 | $242 | $13 |
2022: 4 drugs
| Ipratropium | 14 | $862 | $62 |
| Ofloxacin | 11 | $465 | $42 |
| Montelukast | 12 | $324 | $27 |
| Amoxicillin-Clavulanate Potass | 11 | $121 | $11 |
2021: 2 drugs
| Fluocinolone Acetonide Oil | 24 | $936 | $39 |
| Ofloxacin | 11 | $373 | $34 |
2020: 3 drugs
| Fluocinolone Acetonide Oil | 17 | $854 | $50 |
| Ofloxacin | 12 | $705 | $59 |
| Amoxicillin-Clavulanate Potass | 11 | $134 | $12 |
2019: 3 drugs
| Fluocinolone Acetonide Oil | 12 | $1,173 | $98 |
| Levothyroxine | 13 | $187 | $14 |
| Calcitriol | 12 | $174 | $15 |
2018: 4 drugs
| Fluocinolone Acetonide Oil | 11 | $1,377 | $125 |
| Fluticasone Propionate | 14 | $456 | $33 |
| Hydrocodone-Acetaminophen | 13 | $217 | $17 |
| Amoxicillin-Clavulanate Potass | 19 | $217 | $11 |
2017: 5 drugs
| Fluocinolone Acetonide Oil | 16 | $2,373 | $148 |
| Azelastine | 19 | $1,285 | $68 |
| Fluticasone Propionate | 38 | $748 | $20 |
| Cephalexin | 13 | $92 | $7 |
| Hydrocodone-Acetaminophen | 12 | $50 | $4 |
2016: 7 drugs
| Fluocinolone Acetonide Oil | 16 | $2,548 | $159 |
| Fluticasone Propionate | 43 | $744 | $17 |
| Ofloxacin | 13 | $366 | $28 |
| Levothyroxine | 24 | $320 | $13 |
| Hydrocodone-Acetaminophen | 16 | $241 | $15 |
| Cephalexin | 11 | $79 | $7 |
| Levofloxacin | 11 | $71 | $6 |
2015: 4 drugs
| Fluocinolone Acetonide Oil | 16 | $2,640 | $165 |
| Ofloxacin | 15 | $1,101 | $73 |
| Fluticasone Propionate | 52 | $582 | $11 |
| Amoxicillin-Clavulanate Potass | 15 | $258 | $17 |
2014: 6 drugs
| Nasonex | 12 | $2,321 | $193 |
| Fluticasone Propionate | 74 | $1,131 | $15 |
| Azelastine | 16 | $751 | $47 |
| Ofloxacin | 20 | $707 | $35 |
| Omeprazole | 17 | $361 | $21 |
| Hydrocodone-Acetaminophen | 11 | $81 | $7 |
2013: 2 drugs
| Fluticasone Propionate | 55 | $1,479 | $27 |
| Ofloxacin | 15 | $437 | $29 |
Money from drug and device companies
$63 in 2025
| 2025 | 2 | 2 | None | $63 |
| 2022 | 1 | 1 | None | $60 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Boston Scientific | Obsidio | $39 | 1 payment
|
| Smith+Nephew | Tula | $25 | 1 payment
|
See all 2 published payments
| Boston Scientific | Meals · 2025-07-16 | Obsidio | $39 |
| Smith+Nephew | Meals · 2025-05-01 | Tula | $25 |
See earlier years (2022)
2022: $60
| Horizon Therapeutics plc | Tepezza | $60 | 1 payment
|
Professional record
- NPI
- 1588712525
- Licence
- CA A91564California A91564: Current · expires 2026-11-30
- Trained
- University of California, Irvine, California College of Medicine, 1998
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207YX0007X (207YX0007X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2007-01-08
- NPI last updated
- 2011-12-07
This is when the NPI record was last certified, not a medical board exam.